Trial Profile
Comparison between filgrastim and filgrastim biosimilar in mobilisation of stem cells
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Dec 2015
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary)
- Indications Acute myeloid leukaemia; Hodgkin's disease; Multiple myeloma; Myeloma; Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- 22 Dec 2015 New trial record